Guardian Bio

Guardian Bio YC Application

Summer 2022Active

Guardian Bio went through Y Combinator in the Summer 2022 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Summer 2022
Industry
HealthcareTherapeutics
Team size
2
Status
Active
Launched
2022

Founders

  • Ananya Zutshi
    Ananya ZutshiFounder
  • Ricky Barrett
    Ricky BarrettFounder

What Guardian Bio does

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Guardian Bio's YC application, reconstructed

Y Combinator application

Guardian Bio, Summer 2022 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Guardian Bio

Describe what your company does in 50 characters or less.

Dendritic cell-based platform for cancer therapy

What is your company going to make? Please describe your product and what it does or will do.

We create a dendritic cell therapy for cancer patients. Our product takes stem cells from a patient, turns them into therapeutic dendritic cells trained to recognize that patient's tumor, and puts them back to activate the immune system to fight cancer.

Where do you live now, and where would the company be based after YC?

We currently live in Boston, MA, and the company will be based there after YC as well.

Explain your decision regarding location.

Boston is a hub for biotech and medical research with access to leading hospitals and academic collaborators, which is critical for our work developing cellular therapies.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real Guardian Bio YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Guardian Bio's public data (launch notes, founder backgrounds, product description). It shows how a company like Guardian Bio would present itself to YC, not the text they submitted.

What YC batch was Guardian Bio in?

Guardian Bio was part of the Y Combinator Summer 2022 batch.

Who founded Guardian Bio?

Guardian Bio was founded by Ananya Zutshi, Ricky Barrett.

What does Guardian Bio do?

Dendritic cell-based platform for cancer therapy

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Guardian Bio's application, and every other YC batch, is in YC Insights.

More YC startups like Guardian Bio